跳至主要内容
临床试验/NCT05694286
NCT05694286已完成不适用

A Prospective Evaluation of Infraorbital Filler Injection

University of Pennsylvania2 个研究点 分布在 1 个国家目标入组 11 人开始时间: 2023年1月6日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
11
试验地点
2
主要终点
Volumetric Change in Infraorbital Treatment Baseline to Each Post-intervention Timepoint Day 14, Day 30, and Day 90

研究概览

简要总结

The goal of this clinical trial is to measure the facial volumetric changes over time in patients injected with hyaluronic acid dermal filler (Juvéderm Volbella XC) in the infraorbital (under eye) region. Participants will be injected with Juvéderm Volbella XC filler and asked to return for 3D photography at 2 weeks, 1 month, and 3 months post-injection.

详细描述

Undereye or infraorbital hollowing is a result of a loss of volume causing shadowing and darkness of the infraorbital region often interpreted as a tired, stressed, and aged appearance.

The goal of this clinical trial is to measure the facial volumetric changes over time in patients injected with hyaluronic acid dermal filler (Juvéderm Volbella XC) in the infraorbital (under eye) region. Participants will be injected with Juvéderm Volbella XC filler and asked to return for 3D photography and to complete a validated patient satisfaction questionnaire at 2 weeks, 1 month, and 3 months post-injection. 3D photogrammetry technology allows for high level feature enhancement and microscopic anatomical evaluation that was not previously possible and can be used to make volumetric measurements at injection sites to evaluating minimally invasive injection efficacy.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
22 Years 至 65 Years(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • age 22 to 65
  • interested in filler injections to reduce undereye volume loss

排除标准

  • age <22 or >65
  • prior undereye filler
  • filler/neurotoxin injection within the past 12 months
  • prior facial cosmetic surgery
  • prior facial trauma
  • planned dental work within next 2 weeks
  • travel 1 week prior or 2 weeks after injection

研究组 & 干预措施

Infraorbital Filler

Experimental

Receives 1-2mL injection of approved filler in infraorbital region

干预措施: Juvederm Volbella XC hyaluronic acid dermal filler injection (Procedure)

结局指标

主要结局

Volumetric Change in Infraorbital Treatment Baseline to Each Post-intervention Timepoint Day 14, Day 30, and Day 90

时间窗: Post-intervention, Day 14, Day 30, Day 90

3D facial imaging to measure volumetric changes in the infraorbital region

次要结局

  • Patient Satisfaction With Validated the Questionnaire FACE-Q(Day 0 pre-intervention, Day 0 post-intervention, Day 14, Day 30, Day 90)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Ivona Percec

Principal Investigator

University of Pennsylvania

研究点 (2)

Loading locations...

相似试验